Support for LAist comes from
Audience-funded nonprofit news
Stay Connected
Audience-funded nonprofit news
Listen
Podcasts Take Two
Abuse-deterrent formulation drugs: can they impede the opioid crisis?
solid orange rectangular banner
()
Dec 16, 2016
Listen 9:41
Abuse-deterrent formulation drugs: can they impede the opioid crisis?
There are no easy answers when it comes to dealing with this crisis...but some drug companies believe that new versions of these drugs could play a big part.
Teenagers are most at risk for opioid poisoning, but the rate more than doubled for toddlers from 1997 to 2012.
()

There are no easy answers when it comes to dealing with this crisis...but some drug companies believe that new versions of these drugs could play a big part.

Since 2000, opioid pain medications have been involved in the deaths of more than 165,000 Americans.

There are no easy answers when it comes to dealing with this crisis, but some drug companies believe that new versions of these drugs could play a big part. 

Now they're trying to spread that message to regulators and lawmakers. 

Associated Press reporter Geoff Mulvihill and Liz Essley Whyte of the Center for Public Integrity have spent most of this year poring over hundreds of documents and lobbying data spanning the last decade. They spoke to Alex Cohen for more.

To hear the full interview, click the blue play button above.